Answers are grounded in this paper and cite their sources.
This editorial reviews a recently published guideline on management of irritable bowel syndrome. The guideline illustrates problems arising from the quality of clinical trials used in systematic reviews and the potential impact of the inherent weaknesses of those trials on rating the strength of evidence and the resulting recommendations.
No takes yet. Share an insight, caveat, or question.
Michael Camilleri (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: